Zenex Animal Health has acquired Zenex Animal Health for an undisclosed amount, marking a significant consolidation within the Indian animal healthcare sector. The acquired entity, a prominent player with a nearly seven-decade legacy, has established itself as a leading Indian animal health company, offering an extensive range of products for large and small ruminants, poultry, and companion animals.
The acquired Zenex Animal Health is known for its leadership in many product segments, including innovative herbal offerings. It has a strong track record of introducing novel and first-to-market products, such as the Bacillus Siamensis ZMT02 probiotic strain for poultry. The company operates two state-of-the-art manufacturing facilities in Haridwar and Baddi, serving both domestic and international markets across Asia, Africa, CIS, EU, LATAM, and MENA regions. Its commitment to research is evidenced by over 800 publications.
This acquisition is strategically poised to enhance the acquiring Zenex Animal Health's market position and operational capabilities. By integrating the acquired entity's extensive product portfolio, innovative R&D pipeline, and established manufacturing infrastructure, the combined entity is expected to achieve significant synergies. The move will likely strengthen market penetration, broaden the solution-based technical services offered to dairy and poultry farming communities, and further solidify its international business footprint, leveraging the acquired company's global reach and award-winning excellence.
The combined Zenex Animal Health is set to reinforce its leadership in the Indian animal health industry. This strategic integration aims to drive continued innovation, expand its comprehensive product offerings, and enhance its ability to meet the evolving needs of the animal healthcare fraternity, both domestically and in its international markets.